Biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals
- Year invested 2012
- Investment Stage Public/PIPES
- Sectors
- Investment Status Current
- Website alimerasciences.com
- Company Status IPO/Public (Nasdaq: ALIM)